| |
| |
|
| Insider
Information: |
Ericson William W. |
| Relationship: |
10% Owner |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
18,795 |
|
|
Indirect Shares
|
13,410,159 |
|
|
| Direct
Value |
$41,913 |
|
|
|
Indirect Value
|
$322,996,905 |
|
|
| Total
Shares |
13,428,954 |
|
|
| Total
Value |
$323,038,818 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -6.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pacific Biosciences Of Californi... |
PACB |
Director |
2023-03-15 |
18,795 |
2022-03-17 |
0 |
Premium* |
|
|
Rocket Fuel Inc. |
FUEL |
Director, 10% Owner |
2017-09-06 |
0 |
2014-01-30 |
9,295,955 |
Premium* |
|
|
Adamas Pharmaceuticals Inc |
ADMS |
Director, 10% Owner |
2021-11-24 |
0 |
2021-11-24 |
0 |
Premium* |
|
|
Coupa Software Inc |
COUP |
10% Owner |
2016-10-12 |
0 |
2017-07-12 |
3,986,700 |
Premium* |
|
|
Personalis, Inc. |
PSNL |
10% Owner |
2019-06-24 |
0 |
2019-06-24 |
127,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
64 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2014-04-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,742,702 |
|
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2014-04-15 |
4 |
B |
$16.00 |
$4,800,000 |
I/I |
300,000 |
25,661 |
2.25 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2014-04-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,541,312 |
511,328 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2015-03-17 |
4 |
AS |
$18.00 |
$81,414 |
I/I |
(4,523) |
506,805 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2015-03-18 |
4 |
AS |
$18.04 |
$129,893 |
I/I |
(7,200) |
499,605 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2015-04-10 |
4 |
AS |
$18.56 |
$688,056 |
I/I |
(37,078) |
462,527 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2015-05-18 |
4 |
AS |
$18.04 |
$29,640 |
I/I |
(1,643) |
460,884 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2015-05-28 |
4 |
AS |
$18.02 |
$134,821 |
I/I |
(7,483) |
453,401 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2015-05-29 |
4 |
AS |
$18.02 |
$2,019,555 |
I/I |
(112,073) |
341,328 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2015-06-18 |
4 |
AS |
$27.54 |
$436,251 |
I/I |
(15,842) |
325,486 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2015-07-07 |
4 |
AS |
$27.55 |
$708,931 |
I/I |
(25,737) |
299,749 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2015-07-08 |
4 |
AS |
$27.55 |
$85,408 |
I/I |
(3,100) |
296,649 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2015-07-10 |
4 |
AS |
$27.53 |
$238,308 |
I/I |
(8,657) |
287,992 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2016-09-02 |
4 |
B |
$14.75 |
$644,921 |
I/I |
43,719 |
3,816,405 |
2.25 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2016-09-06 |
4 |
B |
$15.00 |
$107,980 |
I/I |
7,200 |
3,823,605 |
2.25 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2016-09-07 |
4 |
B |
$15.68 |
$954,065 |
I/I |
60,846 |
3,884,451 |
2.25 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2016-09-12 |
4 |
B |
$15.65 |
$349,735 |
I/I |
22,342 |
3,906,793 |
2.25 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2016-09-13 |
4 |
B |
$15.56 |
$964,995 |
I/I |
62,034 |
3,968,827 |
2.25 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2016-09-14 |
4 |
B |
$16.43 |
$895,787 |
I/I |
54,537 |
4,023,364 |
2.25 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2016-09-15 |
4 |
B |
$16.50 |
$3,300 |
I/I |
200 |
4,023,564 |
2.17 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2016-09-16 |
4 |
B |
$16.81 |
$138,497 |
I/I |
8,240 |
4,031,804 |
2.25 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2020-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,000 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2021-11-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
0 |
0 |
- |
|
| ADMS |
Adamas Pharmaceuticals In... |
Director |
– • • |
2021-11-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,619,796) |
0 |
0 |
- |
|
64 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
